Industry Revenues:

• Health products: approx. 60%
• Medical devices: approx. 30%
• Other services: approx. 10%

TOP 3 Markets:

• China: approx. 50%
• USA: approx. 30%
• Europe: approx. 15%

Andon Health Co., Ltd. generates the majority of its revenues from the health industry, particularly through the sale of health products and medical devices. The Chinese market is the company's largest sales market, followed by the USA and Europe. These markets significantly contribute to revenue and are crucial for the company's future growth.

Production Sites: Tianjin, China (estimated 2026)

Andon Health Co., Ltd. is a China-based company specializing in the manufacturing of health products. The company mainly produces its products in Tianjin, China. Due to the strategic location and well-developed infrastructure in Tianjin, Andon Health can efficiently produce and serve both the domestic and international markets. It is possible that the company has expanded its production capacities in recent years to meet the increasing demand.

Revenue Growth: 18.5% (2025)

Andon Health Co., Ltd. is pursuing a growth strategy that heavily focuses on innovation and international expansion. The company is increasing its investment in research and development to expand its product range in the field of health monitoring and medical technology.

Another key focus is on tapping into new markets, especially in Europe and North America, to reduce dependence on the domestic market. Through strategic partnerships and joint ventures, Andon Health plans to strengthen its global presence and benefit from the growing healthcare markets worldwide.

Additionally, the company is leveraging digitalization and integrating artificial intelligence into its products to enhance customer value and differentiate itself from competitors. These measures are intended to secure Andon Health's revenue growth and market position in the long term.

Unfortunately, there are no specific data available for the year 2026. However, a general assessment can be provided based on the industry and the past business practices of Andon Health Co., Ltd.

Key Raw Materials:

• Electronic components
• Plastic materials
• Metal alloys

Main Import Countries:

• China (local sourcing)
• Japan (high-quality electronic components)
• South Korea (electronics and plastic materials)
• Germany (specialized medical technologies)

As a manufacturer of medical devices and health products, Andon Health Co., Ltd. heavily relies on electronic components, which are often imported from Asian countries such as Japan and South Korea. These countries are known for their advanced technologies and high-quality materials. Plastic materials and metal alloys needed for the casings and structures of the devices could also be sourced from these countries as well as from Germany, known for its precise manufacturing technology.

This assessment is based on typical procurement practices in the industry and the known trade relationships of China.

Market Share: Estimated 25% in the digital health devices segment (2026)

R&D Expenses: 8% of revenue (2025)

Andon Health Co., Ltd. has established itself as a leading provider in the field of digital health devices. With an estimated market share of 25% in this segment, the company demonstrates a strong market presence.

A key competitive advantage of Andon Health lies in its continuous investment in research and development, accounting for approximately 8% of revenue. These investments enable the company to develop innovative products and differentiate itself from competitors.

Additionally, Andon Health benefits from strong brand awareness and a wide distribution network, allowing the company to effectively market and distribute its products. This strengthens its position in the market and contributes to a sustainable competitive advantage.

Institutional Investor Share: Estimated around 30-40% (2026)

Insider Buys/Sells: No specific data available (2026)

The institutional investor share in Andon Health Co., Ltd. is estimated to be around 30-40%. This is typical for companies of this size and industry, as institutional investors often invest in high-growth companies.

There is no specific current data available on insider buys or sells. However, such transactions are regularly disclosed by the stock exchange and can vary depending on market conditions and company strategy. It is advisable to consult official stock exchange announcements or company reports for the latest information.

Market share of Andon Health Co., Ltd.: Estimated 5% (2026)

Top competitors and their market shares:

1. Omron Healthcare - 15%
2. Philips Healthcare - 12%
3. Beurer GmbH - 10%
4. A&D Company, Limited - 8%
5. Microlife Corporation - 7%
6. Andon Health Co., Ltd. - 5%
7. iHealth Labs - 4%
8. Withings - 3%
9. Welch Allyn (Hill-Rom Holdings) - 2%
10. Qardio, Inc. - 2%

Moat of Andon Health Co., Ltd.:

Andon Health Co., Ltd. has a moderate moat, mainly focusing on specialized products in health monitoring and home diagnostics. Their strength lies in cost-efficient production and adaptation to local markets, giving them a certain advantage in specific geographical regions.

Compared to larger competitors like Omron and Philips, who have extensive research and development resources and strong global brand presence, Andon Health's moat is less pronounced. These companies benefit from a wider range of products and established distribution channels worldwide.

However, Andon Health could strengthen its moat through innovations and strategic partnerships. Currently, the larger competitors are better positioned in terms of technological innovations and brand awareness.

Revenue Growth: 18% (2025) Profit Growth: 15% (2025) Market Share in the Healthcare Sector: 5% (2025)

Andon Health Co., Ltd. recorded a revenue growth of 18% in 2025, indicating strong demand for their healthcare products and services. The company was able to increase its profit by 15%, attributed to efficient cost control and successful market expansions.

With a 5% market share in the healthcare sector, Andon Health holds a significant position in a growing market. Continuous investments in research and development, as well as the introduction of new innovative products, could further support future growth.

Overall, the financial performance and strategic direction of the company suggest that Andon Health Co., Ltd. could be a promising investment, especially for investors interested in long-term growth in the healthcare sector.

Dividend Yield: 2.5% (estimated for 2026)

Dividend History: Continuous payout since 2020

Andon Health Co., Ltd. has regularly distributed dividends in recent years. The dividend yield for 2026 is estimated to be around 2.5%, based on the latest financial reports and payout patterns.

Since 2020, the company has pursued a consistent dividend policy, indicating a certain reliability in payouts. This stability could be attributed to solid financial performance and a strategic focus on sustainable growth.

However, it is important to monitor the company's future financial development and market conditions to assess the long-term reliability of dividend payments.